Igene Biotechnology Inc's ticker is IGNE and the CUSIP is 451695100. A total of 1 filers reported holding Igene Biotechnology Inc in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,000 | +50.0% | 7,390,923 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 7,390,923 | -11.3% | 0.00% | -100.0% |
| Q1 2019 | $5,000 | +150.0% | 8,336,740 | -0.3% | 0.00% | – |
| Q4 2018 | $2,000 | -50.0% | 8,360,327 | -4.0% | 0.00% | -100.0% |
| Q3 2018 | $4,000 | -60.0% | 8,706,273 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | +900.0% | 8,706,273 | -3.8% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 9,049,487 | +0.2% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 9,029,103 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 9,029,103 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -60.0% | 9,029,103 | +3.1% | 0.00% | -100.0% |
| Q4 2016 | $5,000 | 0.0% | 8,759,708 | -3.0% | 0.00% | 0.0% |
| Q3 2016 | $5,000 | 0.0% | 9,029,103 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | -16.7% | 9,029,103 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $6,000 | +50.0% | 9,036,965 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | -33.3% | 9,025,171 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $6,000 | -95.0% | 9,048,758 | -92.5% | 0.00% | -95.7% |
| Q3 2014 | $120,000 | 0.0% | 120,274,866 | -0.0% | 0.02% | +9.5% |
| Q2 2014 | $120,000 | -56.7% | 120,322,417 | 0.0% | 0.02% | -59.6% |
| Q1 2014 | $277,000 | +63.9% | 120,322,417 | -0.2% | 0.05% | +52.9% |
| Q3 2013 | $169,000 | – | 120,593,142 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kimelman & Baird, LLC | 9,029,103 | $5,000 | 0.00% |